S

SKYE

SKYE

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
SKYE Live QuoteReal-time
$0.79
$0.84(-51.73%)1M
Day Range$0.75 – $1.08
Open$1.04
Previous Close$1.03
Volume168.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.48M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-7.56
Price to Book3.3
Dividend Yield0.65%
Beta (Volatility)3.15
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.79 (26%)
Low: $0.26High: $2.25
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$9.00-94.0% upside

Insider Buys

0

$0

Insider Sales

13

$3.87M

Total Volume

$3.87M

18 transactions

Net Activity

$3.87M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
5
1

5Am Partners Vii, LLC

10%

0 buys4 sells

$1.25M total

S
2

Schwab Andrew J.

Dir, 10%

0 buys4 sells

$1.25M total

A
3

Arsenault Kaitlyn

CFO

0 buys2 sells

$432K total

G
4

Grayson Paul A.

Dir

0 buys1 sells

$432K total

D
5

Dhillon Punit

CEO

0 buys1 sells

$414K total

Trading History
SKYE insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 22, 2026

1 months ago

5Am Partners Vii, LLC

10%

10% Owner
Sell148.1K$1.62$240K

Sep 22, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell981.3K$-148079.00$0

Sep 22, 2026

1 months ago

Schwab Andrew J.

Dir, 10%

Director
Sell148.1K$1.62$240K

Sep 16, 2026

2 months ago

Schwab Andrew J.

Dir, 10%

Director
Sell33.9K$1.91$65K

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.13M$-33892.00$0

Sep 16, 2026

2 months ago

5Am Partners Vii, LLC

10%

10% Owner
Sell33.9K$1.91$65K

Aug 18, 2026

3 months ago

Schwab Andrew J.

Dir, 10%

Director
Sell375.8K$0.37$140K

Aug 18, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell9.31M$-375840.00$0

Aug 18, 2026

3 months ago

5Am Partners Vii, LLC

10%

10% Owner
Sell375.8K$0.37$140K

Aug 21, 2025

15 months ago

5Am Partners Vii, LLC

10%

10% Owner
Sell231.4K$3.46$801K

Aug 21, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell9.68M$-231405.00$0

Aug 21, 2025

15 months ago

Schwab Andrew J.

Dir, 10%

Director
Sell231.4K$3.46$801K

Nov 15, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell167.5K$-43216.00$0

Nov 15, 2024

24 months ago

Arsenault Kaitlyn

CFO

CFO
Sell43.2K$4.99$216K

Nov 15, 2024

24 months ago

Diep Tuan Tu

Chief Development Officer

C-Level
Sell19.6K$4.99$98K

Nov 15, 2024

24 months ago

Arsenault Kaitlyn

CFO

CFO
Sell43.4K$4.99$217K

Nov 15, 2024

24 months ago

Dhillon Punit

CEO

CEO
Sell82.9K$4.99$414K

Nov 15, 2024

24 months ago

Grayson Paul A.

Dir

Director
Sell86.6K$4.99$432K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
SKYE Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

SKYE has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for SKYE

Over the last 90 days, corporate insiders at SKYE (SKYE) engaged in a total of 18 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 13 were sales. The total volume of insider trading reached $3.87M.

The net insider activity for SKYE shows a net selling bias of $3.87M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by 5Am Partners Vii, LLC (10%), who traded 231.4K shares valued at $801K on Aug 21, 2025.

Live Market News & Developments
Aggregated real-time headlines for SKYE (SKYE)
6 updates

SKYE - Skye Bioscience Inc Stock Price and Quote

Finviz178d ago

Skye Bioscience director Andrew Schwab sells $239,555 in common stock

Investing.com56d ago

Skye Bioscience CFO Resigns, CEO Assumes Financial Role

The Globe and Mail69d ago

symbol__ Stock Quote Price and Forecast

CNN951d ago

Skye Bioscience: SKYE Stock Price Quote & News

Robinhood842d ago

Skye’s shares crash down to earth on Phase II obesity loss

Clinical Trials Arena409d ago

FAQs About SKYE Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for SKYE.

Based on SEC Form 4 disclosures, the Insider Confidence Score for SKYE is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 13 sales by company executives over the last 90 days.

The CEO Conviction Index for SKYE is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.